GB2380675B - Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives - Google Patents

Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives

Info

Publication number
GB2380675B
GB2380675B GB0229561A GB0229561A GB2380675B GB 2380675 B GB2380675 B GB 2380675B GB 0229561 A GB0229561 A GB 0229561A GB 0229561 A GB0229561 A GB 0229561A GB 2380675 B GB2380675 B GB 2380675B
Authority
GB
United Kingdom
Prior art keywords
tetrahydropiperine
analogues
nutrients
derivatives
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB0229561A
Other languages
English (en)
Other versions
GB0229561D0 (en
GB2380675A (en
Inventor
Muhammed Majeed
Vladimir Badmaev
Kumar Rajinder Bammi
Subbalakshmi Prakash
Sankaran Natarajan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sami Chemicals and Extracts Ltd
Sabinsa Corp
Original Assignee
Sami Chemicals and Extracts Ltd
Sabinsa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sami Chemicals and Extracts Ltd, Sabinsa Corp filed Critical Sami Chemicals and Extracts Ltd
Publication of GB0229561D0 publication Critical patent/GB0229561D0/en
Publication of GB2380675A publication Critical patent/GB2380675A/en
Application granted granted Critical
Publication of GB2380675B publication Critical patent/GB2380675B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
GB0229561A 2000-05-19 2001-05-21 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives Expired - Lifetime GB2380675B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20524500P 2000-05-19 2000-05-19
US27797901P 2001-03-23 2001-03-23
PCT/US2001/016070 WO2001089571A2 (en) 2000-05-19 2001-05-21 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives

Publications (3)

Publication Number Publication Date
GB0229561D0 GB0229561D0 (en) 2003-01-22
GB2380675A GB2380675A (en) 2003-04-16
GB2380675B true GB2380675B (en) 2004-11-03

Family

ID=26900240

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0229561A Expired - Lifetime GB2380675B (en) 2000-05-19 2001-05-21 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives

Country Status (6)

Country Link
US (1) US6849645B2 (https=)
JP (1) JP4098985B2 (https=)
AU (1) AU2001278849A1 (https=)
DE (2) DE10196213T1 (https=)
GB (1) GB2380675B (https=)
WO (1) WO2001089571A2 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005529123A (ja) * 2002-04-24 2005-09-29 リサーチ　ディベロップメント　ファンデーション 核転写調節因子ＮＦ−κＢ抑制剤と抗腫瘍薬の相乗効果
CA2489947A1 (en) * 2002-06-24 2003-12-31 Research Development Foundation Treatment of human multiple myeloma by curcumin
WO2004067018A1 (en) * 2003-01-30 2004-08-12 Council Of Scientific And Industrial Research Bioavailability enhancing activity of carum carvi extracts and fractions thereof
US7462646B2 (en) 2003-08-26 2008-12-09 Research Development Foundation Osteoclastogenesis inhibitors and uses thereof
US20050163873A1 (en) * 2004-01-14 2005-07-28 Robert Ritch Methods and formulations for treating glaucoma
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US20060130675A1 (en) * 2004-11-30 2006-06-22 Crawford David S Transdermal nutritional supplement delivery patch
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
US20080138417A1 (en) * 2006-11-22 2008-06-12 Charles Grigsby Topical Composition And Method Of Forming
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
WO2017020125A1 (en) * 2015-07-31 2017-02-09 Delivra Inc. Transdermal formulations for delivery of capsaicinoids
KR102655937B1 (ko) * 2016-09-27 2024-04-11 (주)아모레퍼시픽 코스모페린을 포함하는 항스트레스 조성물
WO2018069938A1 (en) * 2016-10-14 2018-04-19 Cipla Limited Pharmaceutical compositions comprising rifaximin
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
WO2019058386A1 (en) * 2017-09-19 2019-03-28 Cipla Limited COMPOSITIONS COMPRISING IBRUTINIB AND AN ALKALOID HAVING IMPROVED BIOAVAILABILITY
EP3801732A4 (en) 2018-05-29 2022-04-27 Morningside Venture Investments Limited METHODS AND SYSTEMS FOR DRUG DELIVERY
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
US20200179362A1 (en) * 2018-12-05 2020-06-11 James E. Beecham Dietary supplement comprising glucuronidation inhibition assist for healthful daily synergy of anti-inflammation, cellular anti-oxidant boost, cellular protein clean-up boost
JP7163261B2 (ja) * 2019-09-27 2022-10-31 富士フイルム株式会社 水中油型乳化組成物、及び皮膚外用剤
CN115670998A (zh) * 2022-11-18 2023-02-03 广州澳莱娜生物科技有限公司 一种祛痘控油亮肤组合物及其制备方法
CN115813822B (zh) * 2022-12-16 2024-06-25 厦门海尼新创生物科技有限公司 一种高效祛痘组合物及其制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023061A1 (en) * 1992-05-21 1993-11-25 Staggs Jeff J Therapeutic uses of pungent botanicals and their related compounds
EP0650728A1 (en) * 1993-10-29 1995-05-03 Council of Scientific and Industrial Research Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug
EP0709098A1 (en) * 1993-10-29 1996-05-01 Cadila Laboratories Limited Compositions containing piperine
JPH08143562A (ja) * 1994-11-04 1996-06-04 Cadila Lab Ltd ピペリンを含む組成物
EP0935964A1 (en) * 1998-02-12 1999-08-18 Panacea Biotec Limited Pharmaceutical compositions containing NSAIDs and piperine
WO2000002544A2 (en) * 1998-07-13 2000-01-20 Btg International Limited Use of piperine for treating skin pigmentation disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001264A1 (fr) * 1982-09-30 1984-04-12 Dainippon Jochugiku Kk Appareil de volatilisation thermique d'un agent medicinal
CA2098889A1 (en) * 1992-07-06 1994-01-07 Takashi Chinuki Slow-releasing medicated resin moldings and process for producing the same
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023061A1 (en) * 1992-05-21 1993-11-25 Staggs Jeff J Therapeutic uses of pungent botanicals and their related compounds
EP0650728A1 (en) * 1993-10-29 1995-05-03 Council of Scientific and Industrial Research Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug
EP0709098A1 (en) * 1993-10-29 1996-05-01 Cadila Laboratories Limited Compositions containing piperine
JPH08143562A (ja) * 1994-11-04 1996-06-04 Cadila Lab Ltd ピペリンを含む組成物
EP0935964A1 (en) * 1998-02-12 1999-08-18 Panacea Biotec Limited Pharmaceutical compositions containing NSAIDs and piperine
WO2000002544A2 (en) * 1998-07-13 2000-01-20 Btg International Limited Use of piperine for treating skin pigmentation disorders

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHIMICA OGGI, v19, no1/2. Jan 2001, pp53-57. VLADIMIR BADMAEV ET AL *
HOUSEHOLD PERS. PROD. IND. v38, no3. MAR 2001, pp96, 98-99. VLADIMIR BADMAEV ET AL *
Indian Journal of Experimental Biology, Vol. 15, No. 12, 1977, (ATAL C.K. et al) pages 1230-1232 *
WPI Abstract Acc. No. 1996-318931 [33] & JP 8143562 A (KADEIRA LAB LTD) *

Also Published As

Publication number Publication date
US6849645B2 (en) 2005-02-01
JP4098985B2 (ja) 2008-06-11
WO2001089571A2 (en) 2001-11-29
DE10196213T1 (de) 2003-04-30
JP2003534295A (ja) 2003-11-18
DE10196213B4 (de) 2020-12-17
GB0229561D0 (en) 2003-01-22
WO2001089571A3 (en) 2002-03-07
GB2380675A (en) 2003-04-16
AU2001278849A1 (en) 2001-12-03
US20020058695A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
GB2380675B (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
AU6271401A (en) Drug administering system and administering method
AU4796700A (en) Ureido-substituted cyclic amine derivatives and their use as drug
PL344218A1 (en) Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
NZ513983A (en) Novel cyclic tetrapeptide derivatives and use thereof as drugs
NO20014994D0 (no) Hvitt pulver og fremgangsmåte for fremstilling derav
IL147774A0 (en) Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production
HUP0302050A3 (en) Pharmaceutical form of administration for peptides, method for its production and use
AU772782C (en) Cyclic peptide derivatives as inhibitors of integrin alphavbeta6
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
PL352293A1 (en) Derivatives of purine, method of making same and pharmaceutical compositions containing these derivatives
IS6723A (is) 10-arýl-11H-bensó[b]flúorenafleiður og hliðstæðurtil lyfjanotkunar
GB9924334D0 (en) Pharmaceutical products and methods of fabrication therefor
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
IL146449A0 (en) Method and pharmaceutical preparations for reducing the activity of cells
HUP0303694A3 (en) Aza-amino acid derivatives and pharmaceutical
PL359208A1 (en) New derivatives of quinosoline, method of production of new derivatives of quinosoline and pharmaceutical preparations
AU2001252741A1 (en) Pharmaceutical composition containing itraconazole with gastric ph-independentlyimproved solubility and preparation method thereof
AU2002223013A1 (en) Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
PT1206253E (pt) Preparacoes farmaceuticas solidas contendo nanossois de quitosano e metodo de preparacao
HUP0200812A3 (en) Vitamin d analogues and their pharmaceutical use
NO20020777D0 (no) Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav
AU1887301A (en) Heterocycle derivatives and drugs
AU6046900A (en) Method for increasing the solubility of morphine and pharmaceutical compositionsprepared therefrom

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20210520